UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: June 28, 2024 5:30 P.M.
Form: S-1
CIK: 0000109657
Company Name: GT Biopharma, Inc.
File Number: 333-280326